Literature DB >> 14998343

Arecoline tripeptide inhibitors of proteasome.

Mauro Marastoni1, Anna Baldisserotto, Alessandro Canella, Riccardo Gavioli, Carmela De Risi, Gian Piero Pollini, Roberto Tomatis.   

Abstract

The 26S proteasome is a multicatalytic protease complex that plays an essential role in intracellular protein degradation. We have synthesized and tested a series of arecoline peptide derivatives where the peptide portion derives from a screening of tripeptide sequences, and the arecoline moiety has been considered as a potential substrate for catalytic threonine. Derivatives 17-19 are the best compounds of the series, showing chymotryptic-like (beta5) inhibition (IC(50) congruent with 1 microM) and favorable pharmacokinetic properties.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14998343     DOI: 10.1021/jm0309102

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  6 in total

1.  Fundamental reaction pathway for peptide metabolism by proteasome: insights from first-principles quantum mechanical/molecular mechanical free energy calculations.

Authors:  Donghui Wei; Lei Fang; Mingsheng Tang; Chang-Guo Zhan
Journal:  J Phys Chem B       Date:  2013-10-10       Impact factor: 2.991

2.  Synthesis and Biological Activity of Peptide α-Ketoamide Derivatives as Proteasome Inhibitors.

Authors:  Salvatore Pacifico; Valeria Ferretti; Valentina Albanese; Anna Fantinati; Eleonora Gallerani; Francesco Nicoli; Riccardo Gavioli; Francesco Zamberlan; Delia Preti; Mauro Marastoni
Journal:  ACS Med Chem Lett       Date:  2019-06-06       Impact factor: 4.345

3.  Fundamental reaction pathway and free energy profile for inhibition of proteasome by Epoxomicin.

Authors:  Donghui Wei; Beilei Lei; Mingsheng Tang; Chang-Guo Zhan
Journal:  J Am Chem Soc       Date:  2012-06-14       Impact factor: 15.419

4.  Fundamental reaction pathway and free energy profile of proteasome inhibition by syringolin A (SylA).

Authors:  Donghui Wei; Mingsheng Tang; Chang-Guo Zhan
Journal:  Org Biomol Chem       Date:  2015-06-28       Impact factor: 3.876

Review 5.  Revisiting Proteasome Inhibitors: Molecular Underpinnings of Their Development, Mechanisms of Resistance and Strategies to Overcome Anti-Cancer Drug Resistance.

Authors:  Carlota Leonardo-Sousa; Andreia Neves Carvalho; Romina A Guedes; Pedro M P Fernandes; Natália Aniceto; Jorge A R Salvador; Maria João Gama; Rita C Guedes
Journal:  Molecules       Date:  2022-03-28       Impact factor: 4.411

6.  Peptide and Peptide-Like Modulators of 20S Proteasome Enzymatic Activity in Cancer Cells.

Authors:  Carlos García-Echeverría
Journal:  Int J Pept Res Ther       Date:  2006-03-04       Impact factor: 1.931

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.